Kezar Life Sciences, INC. (KZR) — 8-K Filings

All 8-K filings from Kezar Life Sciences, INC.. Browse 18 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (18)

Kezar Life Sciences Files 8-K for Material Agreement — Mar 30, 2026 Risk: medium
Kezar Life Sciences, Inc. filed an 8-K on March 30, 2026, to report the entry into a material definitive agreement. The filing also includes Regulation FD discl
Kezar Life Sciences Reports Exit/Disposal Costs — Nov 7, 2025 Risk: medium
Kezar Life Sciences, Inc. filed an 8-K on November 7, 2025, reporting costs associated with exit or disposal activities as of November 6, 2025. The filing does
Kezar Life Sciences Terminates Material Agreement — Oct 22, 2025 Risk: medium
Kezar Life Sciences, Inc. announced on October 20, 2025, the termination of a material definitive agreement. The filing does not specify the counterparty or the
Kezar Life Sciences Files 8-K with Key Updates — Oct 16, 2025 Risk: medium
Kezar Life Sciences, Inc. filed an 8-K on October 16, 2025, reporting on several key events. These include entering into a material definitive agreement, update
Kezar Life Sciences Files 8-K on Shareholder Matters — Jun 23, 2025 Risk: low
Kezar Life Sciences, Inc. filed an 8-K on June 23, 2025, reporting on matters submitted to a vote of security holders as of June 17, 2025. The filing details th
Kezar Life Sciences Files 8-K on Officer/Director Changes — Apr 1, 2025 Risk: low
Kezar Life Sciences, Inc. filed an 8-K on April 1, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment
Kezar Life Sciences Files 8-K — Feb 27, 2025 Risk: low
Kezar Life Sciences, Inc. filed an 8-K on February 27, 2025, reporting other events and financial statements. The filing details the company's principal executi
Kezar Life Sciences Files 8-K on Financials — Jan 10, 2025 Risk: low
Kezar Life Sciences, Inc. filed an 8-K on January 10, 2025, reporting on its Results of Operations and Financial Condition. The filing details the company's sta
Kezar Life Sciences Files 8-K on Material Agreements — Dec 3, 2024 Risk: medium
Kezar Life Sciences, Inc. filed an 8-K on December 3, 2024, reporting a material definitive agreement and material modifications to the rights of security holde
Kezar Life Sciences Faces Nasdaq Delisting Warning — Nov 14, 2024 Risk: medium
Kezar Life Sciences, Inc. announced on November 13, 2024, that it received a notice from the Nasdaq Stock Market indicating non-compliance with listing rules. T
Kezar Life Sciences Files 8-K with Corporate Updates — Oct 28, 2024 Risk: low
Kezar Life Sciences, Inc. filed an 8-K on October 28, 2024, reporting material modifications to the rights of security holders and amendments to its articles of
Kezar Life Sciences Files 8-K — Oct 17, 2024 Risk: low
Kezar Life Sciences, Inc. filed an 8-K on October 17, 2024, reporting on several items including entry into a material definitive agreement, results of operatio
Kezar Life Sciences Files 8-K — Oct 10, 2024 Risk: low
Kezar Life Sciences, Inc. filed an 8-K on October 10, 2024, to report other events and financial statements. The filing does not contain specific details about
Kezar Life Sciences Files 8-K — Oct 4, 2024 Risk: low
Kezar Life Sciences, Inc. filed an 8-K on October 4, 2024, reporting other events and financial statements. The filing does not contain specific details about t
Kezar Life Sciences Files 8-K — Sep 30, 2024 Risk: low
Kezar Life Sciences, Inc. filed an 8-K on September 30, 2024, reporting other events and financial statements. The filing does not contain specific financial fi
Kezar Life Sciences Reports on Shareholder Vote Matters — Jun 21, 2024 Risk: low
Kezar Life Sciences, Inc. filed an 8-K on June 21, 2024, reporting on matters submitted to a vote of security holders on June 18, 2024. The filing details the c
Kezar Life Sciences Faces Delisting Concerns — Jun 4, 2024 Risk: high
Kezar Life Sciences, Inc. filed an 8-K on May 31, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is based in
Kezar Life Sciences Files 8-K on Financial Condition — Jan 8, 2024
Kezar Life Sciences, Inc. filed an 8-K on January 8, 2024, under Item 2.02, 'Results of Operations and Financial Condition.' This filing indicates that the comp

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX